DUBLIN (AP) — DUBLIN (AP) — Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $10.5 million in its first quarter. On a per-share basis, the Dublin-based company said it had a loss of 60 cents.

The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...

Officials contained an oil spill in Nan after a tanker carrying fuel to Laos overturned and leaked 5,000 litres on a Thung Chang road.

A motorcycle plunged into a construction pit in Nonthaburi, injuring two people before rescuers pulled an unconscious woman from below.

DUBLIN and BRIDGEWATER, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced that ...

Amarin ( (AMRN)) has issued an announcement. On March 25, 2026, Amarin’s board moved to streamline its governance structure by reducing the size of the board from nine to seven directors, following ...

DUBLIN and BRIDGEWATER, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) ...

Amarin has one drug, and it has lost key patent protections. The company is cutting costs in an effort to generate positive cash flow. Perhaps the most positive thing about Amarin is its balance sheet ...

Amarin (NASDAQ: AMRN) is a drug company that is in a particularly precarious position. This fact is highlighted by the company's recent move to restructure its operations in an effort to cut costs.

Broader equities have been relatively volatile over the past few months. In an environment like this, it's best to prioritize investing in well-established, profitable corporations. While small-cap ...